BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16676271)

  • 1. The impact of parallel chemistry in drug discovery.
    Edwards PJ
    IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of statistical 'design of experiments' methods in drug discovery.
    Tye H
    Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we rationally design promiscuous drugs?
    Hopkins AL; Mason JS; Overington JP
    Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern natural products chemistry and drug discovery.
    Ojima I
    J Med Chem; 2008 May; 51(9):2587-8. PubMed ID: 18393400
    [No Abstract]   [Full Text] [Related]  

  • 6. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 7. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of microwave-assisted organic synthesis in drug discovery.
    Mavandadi F; Pilotti A
    Drug Discov Today; 2006 Feb; 11(3-4):165-74. PubMed ID: 16533715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 10. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles.
    Polshettiwar V; Varma RS
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):723-37. PubMed ID: 17987524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific workflows as productivity tools for drug discovery.
    Shon J; Ohkawa H; Hammer J
    Curr Opin Drug Discov Devel; 2008 May; 11(3):381-8. PubMed ID: 18428092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective use of preparative chiral HPLC in a preclinical drug synthesis.
    Nelson TD; Welch CJ; Rosen JD; Smitrovich JH; Huffman MA; McNamara JM; Mathre DJ
    Chirality; 2004 Nov; 16(9):609-13. PubMed ID: 15390084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand efficiency indices as guideposts for drug discovery.
    Abad-Zapatero C; Metz JT
    Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
    [No Abstract]   [Full Text] [Related]  

  • 18. Automated medicinal chemistry.
    Koppitz M; Eis K
    Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous flow microreactors for drug discovery.
    Watts P
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):807-12. PubMed ID: 15595441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.